R&D in Healthcare
Vibrant science across the globe
Patients are at the center of all our research and development efforts. We are committed to innovation in science that will ultimately make a meaningful difference in people’s lives all over the world. Ever since Merck KGaA, Darmstadt, Germany, was founded 350 years ago, we have gained unmatched experience in the discovery, development and manufacturing of medicines.
On top of leveraging our experience and expertise, we also believe that a healthier future deserves a sizable investment. In 2018 our Healthcare business devoted roughly 20% of total sales to R&D activities aimed at discovering and developing new therapies. All of these are integrated in a global organization with six strategic locations and highly connected hubs: Darmstadt, Boston, Beijing, Tokyo, Bangalore, and Yavne.
Latest R&D NewsView All News
Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for arpraziquantel.
Two Phase III EVOLUTION clinical trials of evobrutinib did not meet their primary endpoints.
We successfully integrated p-Chip's microtransponder technology as a crypto-anchor into a cyber-physical trust framework solution developed by us.